Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA advisory panel approves carvedilol

March 3, 1997

Posicor recommended for approval in the U.S.

March 3, 1997

Symphar/SKB disclose compounds with Lp(a)-lowering activity

March 3, 1997

New clinical results for Cypros' CPC-111

Feb. 28, 1997

Positive results reported for VasoCare in MI

Feb. 27, 1997

Harvard College discloses vascular injury-associated gene

Feb. 27, 1997

Cytel and Sumitomo expand agreement

Feb. 26, 1997

Bayer and Zeneca to comarket Ca antagonist

Feb. 26, 1997

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....